Nerve growth factor receptor TrkA signaling in breast cancer cells involves Ku70 to prevent apoptosis

Molecular and Cellular Proteomics

Volumn 6, Issue 11, 2007, Pages 1842-1854

  Com, Emmanuelle ^a   Lagadec, Chann ^a   Page, Adeline ^b   El Yazidi Belkoura, Ikram ^a   Siomianny, Christian ^a   Spencer, Ambre ^c   Hammache, Djilali ^c   Rudkin, Brian B ^c   Hondermarck, Hubert ^a  

^a INSERM   (France)

^b UNIV LILLE   (France)

^c UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ATP DEPENDENT RNA HELICASE; BETA ACTIN; CHIMERIC PROTEIN; CYCLINE; ELONGATION FACTOR 2; FIBRILLARIN; GAMMA ACTIN; GLUCOSE REGULATED PROTEIN; GREEN FLUORESCENT PROTEIN; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 71; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN U; INTERLEUKIN ENHANCER BINDING FACTOR 2; IQ MOTIF CONTAINING GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN 1; KU ANTIGEN; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; NUCLEOPHOSMIN; PHOSPHOTYROSINE; PROTEIN TYROSINE KINASE A; RNA HELICASE; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG; VALOSIN CONTAINING PROTEIN;

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CARCINOGENESIS; CELL SURVIVAL; CONFOCAL MICROSCOPY; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NERVE CELL DIFFERENTIATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; WESTERN BLOTTING; WILD TYPE;

AMINO ACID SEQUENCE; ANTIGENS, NUCLEAR; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; DNA-BINDING PROTEINS; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOPRECIPITATION; MOLECULAR SEQUENCE DATA; NERVE GROWTH FACTOR; RECEPTOR, TRKA; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 36749055667     PISSN: 15359476     EISSN: None     Source Type: Journal    
DOI: 10.1074/mcp.M700119-MCP200     Document Type: Article

References (59)

1. Bibel, M., and Barde, Y. A. (2000) Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system. Genes Dev. 14, 2919-2937
2. Huang, E. J., and Reichardt, L. F. (2001) Neurotrophins: roles in neuronal development and function. Annu. Rev. Neurosci. 24, 677-736
3. Davidson, B., Reich, R., Lazarovici, P., Nesland, J. M., Skrede, M., Risberg, B., Trope, C. G., and Florenes, V. A. (2003) Expression and activation of the nerve growth factor receptor TrkA in serous ovarian carcinoma. Clin. Cancer Res. 9, 2248-2259
4. Geldof, A. A, Van Haarst, E. P., and Newling, D. W. (1998) Neurotrophic factors in prostate and prostatic cancer. Prostate Cancer Prostatic Dis. 1, 236-241
5. Zhu, Z., Kleeff, J., Kayed, H., Wang, L., Korc, M., Buchler, M. W., and Friess, H. (2002) Nerve growth factor and enhancement of proliferation, invasion, and turnorigenicity of pancreatic cancer cells. Mol. Carcinog. 35, 138-147
6. Ricci, A., Graziano, P., Mariotta, S., Cardillo, G., Sposato, B., Terzano, C., and Bronzetti, E. (2005) Neurotrophin system expression in human pulmonary carcinoid tumors. Growth Factors 23, 303-312
7. Dolle, L, Adriaenssens, E., El Yazidi-Belkoura, I., Le Bourhis, X., Nurcombe, V., and Hondermarck, H. (2004) Nerve growth factor receptors and signaling in breast cancer. Curr. Cancer Drug Targets 4, 463-470
8. Descamps, S., Lebourhis, X., Delehedde, M., Boilly, B., and Hondermarck, H. (1998) Nerve growth factor is mitogenic for cancerous but not normal human breast epithelial cells. J. Biol. Chem. 273, 16659-16662
9. Descamps, S., Toillon, R. A., Adriaenssens, E., Pawlowski, V., Cool, S. M., Nurcombe, V., Le Bourhis, X., Boilly, B., Peyrat, J. P., and Hondermarck, H. (2001) Nerve growth factor stimulates proliferation and survival of human breast cancer cells through two distinct signaling pathways. J. Biol. Chem. 276, 17864-17870
10. Dolle, L., El Yazidi-Belkoura, I., Adriaenssens, E., Nurcombe, V., and Hon-dermarck, H. (2003) Nerve growth factor overexpression and autocrine loop in breast cancer cells. Oncogene 22, 5592-5601
11. Descamps, S., Pawlowski, V., Revillion, F., Hornez, L, Hebbar, M., Boilly, B., Hondermarck, H., and Peyrat, J. P. (2001) Expression of nerve growth factor receptors and their prognostic value in human breast cancer. Cancer Res. 61, 4337-4340
12. Aragona, M., Panetta, S., Silipigni, A. M., Romeo, D. L., Pastura, G., Mesiti, M., Cascinu, S., and LaTorre, F. (2001) Nerve growth factor receptor immunoreactivity in breast cancer patients. Cancer Investig. 19, 692-697
13. Davidson, B., Reich, R., Lazarovici, P., Ann Florenes, V., Nielsen, S., and Nesland, J. M. (2004) Altered expression and activation of the nerve growth factor receptors TrkA and p75 provide the first evidence of tumor progression to effusion in breast carcinoma. Breast Cancer Res. Treat. 83, 119-128
14. Tagliabue, E., Castiglioni, F., Ghirelli, C., Modugno, M., Asnaghi, L., Somenzi, G., Melani, C., and Menard, S. (2000) Nerve growth factor cooperates with p185(HER2) in activating growth of human breast car- cinoma cells. J. Biol. Chem. 275, 5388-5394
15. Melck, D., De Petrocellis, L., Orlando, P., Bisogno, T., Laezza, C., Bifulco, M., and Di Marzo, V. (2000) Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation. Endocrinology 141, 118-126
16. Chiarenza, A., Lazarovici, P., Lempereur, L., Cantarella, G., Bianchi, A., and Bemardini, R. (2001) Tamoxifen inhibits nerve growth factor-induced proliferation of the human breast cancerous cell line MCF-7. Cancer Res. 61, 3002-3008
17. Downs, J. A., and Jackson, S. P. (2004) A means to a DNA end: the many roles of Ku. Nature. 5, 367-378
18. Jullien, J., Guili, V., Derrington, E. A., Darlix, J. L., Reichardt, L. F., and Rudkin, B. B. (2003) Trafficking of TrkA-green fluorescent protein chimerae during nerve growth factor-induced differentiation. J. Biol. Chem. 278, 8706-8716
19. Ayene, I. S., Ford, L. P., Koch, and C. J. (2005) Ku protein targeting by Ku70 small interfering RNA enhances human cancer cell response to topoisomerase II inhibitor and gamma radiation. Mol. Cancer Ther. 4, 529-536
20. Neuhoff, V., Arold, N., Taube, D., and Ehrhardt, W. (1988) Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G-250 and R-250. Electrophoresis 9, 255-262
21. Com, E., Evrard, B., Roepstorff, P., Aubry, F., and Pineau, C. (2003) New insights into the rat spermatogonial proteome: identification of 156 additional proteins. Mol. Cell. Proteomics 2, 248-261
22. Schlessinger, J., and Lemmon, M. A. (2006) Nuclear signaling by receptor tyrosine kinases: the first robin of spring. Cell 127, 45-48
23. Sawada, M., Sun, W., Hayes, P., Leskov, K., Boothman, D. A., and Matsuyama, S. (2003) Ku70 suppresses the apoptotic translocation of Bax to mitochondria. Nat. Cell Biol. 5, 320-329
24. Pandey, A., Andersen, J. S., and Mann, M. (2000) Use of mass spectrometry to study signaling pathways. Sci. STKE 2000, PL1
25. Vercoutter-Edouart, A., Lemoine, J., Smart, C. E., Nurcombe, V., Boilly, B., Peyrat, J., and Hondermarck, H. (2000) The mitogenic signaling pathway for fibroblast growth factor-2 involves the tyrosine phosphorylation of cyclin D2 in MCF-7 human breast cancer cells. FEBS Lett. 478, 209-215
26. Pandey, A., Podtelejnikov, A. V., Blagoev, B., Bustelo, X. R., Mann, M., and Lodish, H. F. (2000) Analysis of receptor signaling pathways by mass spectrometry: identification of vav-2 as a substrate of the epidermal and platelet-derived growth factor receptors. Proc. Natl. Acad. Sci. U. S. A. 97, 179-184
27. Hinsby, A. M., Olsen, J. V., Bennett, K. L., and Mann, M. (2003) Signaling initiated by overexpression of the fibroblast growth factor receptor-1 investigated by mass spectrometry. Mol. Cell. Proteomics 2, 29-36
28. Vandermoere, F., El Yazidi-Belkoura, I., Slomianny, C., Demont, Y., Bidaux, G., Adriaenssens, E., Lemoine, J., and Hondermarck, H. (2006) The valosin-containing protein (VCP) is a target of Akt signaling required for cell survival. J. Biol. Chem. 281, 14307-14313
29. Vandermoere, F., El Yazidi-Belkoura, I., Demont, Y., Slomianny, C., Antol, J., Lemoine, J., and Hondermarck, H. (2007) Proteomic exploration reveals that actin is a signaling target of the kinase Akt. Mol. Cell. Proteomics 6, 114-124
30. Brown, M. D., and Sacks, D. B. (2006) IQGAP1 in cellular signaling: bridging the GAP. Trends Cell Biol. 16, 242-249
31. Blagoev, B., Kratchmarova, I., Ong, S. E., Nielsen, M., Foster, L. J., and Mann, M. (2003) A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling. Nat. Biotechnol. 21, 315-318
32. Wang, Q., Song, C., and Li, C. C. (2004) Molecular perspectives on p97-VCP: progress in understanding its structure and diverse biological functions. J. Struct. Biol. 146, 44-57
33. Klein, J. B., Barati, M. T., Wu, R., Gozal, D., Sachleben, L. R., Jr., Kausar, H., Trent, J. O., Gozal, E., and Rane, M. J. (2005) Akt-mediated valosin-containing protein 97 phosphorylation regulates its association with ubiquitinated proteins. J. Biol. Chem. 280, 31870-31881
34. Stambolic, V., and Woodgett, J. R. (2006) Functional distinctions of protein kinase B/Akt isoforms defined by their influence on cell migration. Trends Cell Biol. 9, 461-466
35. Thomas, D., Patterson, S. D., and Bradshaw, R. A. (1995) Src homologous and collagen (Shc) protein binds to F-actin and translocates to the cytoskeleton upon nerve growth factor stimulation in PC12 cells. J. Biol. Chem. 270, 28924-28931
36. Grisendi, S., Mecucci, C., Falini, B., and Pandolfi, P. P. (2006) Nucleophosmin and cancer. Nat. Rev. Cancer 6, 493-505
37. 3 receptor, mediates the antiapoptotic actions of NGF by inhibiting CAD. Mol. Cell 18, 435-445
38. Ye, K. (2005) PIKE/nuclear PI 3-kinase signaling in preventing programmed cell death. J. Cell. Biochem. 96, 463-472
39. Bandyopadhyay, D., Mandal, M., Adam, L., Mendelsohn, J., and Kumar, R. (1998) Physical interaction between epidermal growth factor receptor and DNA-dependent protein kinase in mammalian cells. J. Biol. Chem. 273, 1568-1573
40. Fewell, J. W., and Kuff, E. L. (1996) Intracellular redistribution of Ku immunoreactivity in response to cell-cell contact and growth modulating components in the medium. J. Cell Sci. 109, 1937-1946
41. Bakalkin, G., Yakovleva, T., Hurd, Y. L., Nussenzweig, A., Li, G. C., and Terenius, L. (1998) Autoantigen Ku in the brain. Developmentally regulated expression and subcellular localization. Neuroreport 9, 2147-2151
42. Koike, M. (2002) Dimerization, translocation and localization of Ku70 and Ku80 proteins. J. Radiat. Res. (Tokyo) 43, 223-236
43. Obenauer, J. C., Cantley, L. C., and Yaffe, M. B. (2003) Scansite 2.0: proteome-wide prediction of cell signaling interactions using short sequence motifs. Nucleic Acids Res. 31, 3635-3641
44. Chao, M. V. (1992) Growth factor signaling: where is the specificity? Cell. 68, 995-997
45. Vaudry, D., Stork, P. J., Lazarovici, P., and Eiden, L. E. (2002) Signaling pathways for PC12 cell differentiation: making the right connections. Science 296, 1648-1649
46. Kao, S., Jaiswal, R. K., Kolch, W., and Landreth, G. E. (2001) Identification of the mechanisms regulating the differential activation of the MAPK cascade by epidermal growth factor and nerve growth factor in PC12 cells. J. Biol. Chem. 276, 18169-18177
47. Marshall, C. J. (1995) Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80, 179-185
48. Meakin, S. O., Macdonald, J. I., Gryz, E. A., Kubu, C. J., and Verdi, J. M. (1999) The signaling adapter FRS-2 competes with Shc for binding to the nerve growth factor receptor TrkA. A model for discriminating proliferation and differentiation. J. Biol. Chem. 274, 9861-9870
49. Billon, N., Van Grunsven, L. A., and Rudkin, B. B. (1996) The CDK inhibitor p21WAF1/Cip1 is induced through a p300-dependent mechanism during NGF-mediated neuronal differentiation of PC12 cells. Oncogene 13, 2047-2054
50. Armstrong D. K., Kaufmann, S. H., Ottaviano, Y. L., Furuya, Y., Buckley, J. A., Isaacs, J. T., and Davidson, N. E. (1994) Epidermal growth factor-mediated apoptosis of MDA-MB-468 human breast cancer cells. Cancer Res. 54, 5280-5283
51. Gulli, L. F., Palmer, K. C., Chen, Y. Q., and Reddy, K. B. (1996) Epidermal growth factor-induced apoptosis in A431 cells can be reversed by reducing the tyrosine kinase activity. Cell Growth Differ. 7, 173-178
52. Maloof, P., Wang, Q., Wang, H., Stein, D., Denny, T. N., Yahalom, J., Fenig, E., and Wieder, R. (1999) Overexpression of basic fibroblast growth factor (FGF-2) downregulates BcI-2 and promotes apoptosis in MCF-7 human breast cancer cells. Breast Cancer Res. Treat. 56, 153-167
53. Mansukhani, A., Bellosta, P., Sahni, M., and Basilico, C. (2000) Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts. J. Cell Biol. 149, 1297-1308
54. Matteucci, E., Modora, S., Simone, M., and Desiderio, M. A. (2003) Hepatocyte growth factor induces apoptosis through the extrinsic pathway in hepatoma cells: favouring role of hypoxia-inducible factor-1 deficiency. Oncogene 22, 4062-4073
55. Kim, M. S., Kim, C. J., Jung, H. S., Seo, M. R., Juhnn, Y. S., Shin, H. Y., Ahn, H. S., Thiele, C. J., and Chi, J. G. (2004) Fibroblast growth factor 2 induces differentiation and apoptosis of Askin tumour cells. J. Pathol. 202, 103-112
56. Muragaki, Y., Chou, T. T., Kaplan, D. R., Trojanowski, J. Q., and Lee, V. M. (1997) Nerve growth factor induces apoptosis in human medulloblastoma cell lines that express TrkA receptors. J. Neurosci. 17, 530-542
57. Lavoie, J. F., Lesauteur, L., Kohn, J., Wong, J., Furtoss, O., Thiele, C. J., Miller, F. D., and Kaplan, D. R. (2005) TrkA induces apoptosis of neuroblastoma cells and does so via a p53-dependent mechanism. J. Biol. Chem. 280, 29199-29207
58. Bredesen, D. E., and Rabizadeh, S. (1997) p75NTR and apoptosis: Trk-dependent and Trk-independent effects. Trends Neurosci. 20, 287-290
59. Gullo, C., Au, M., Feng, G., and Teoh, G. (2006) The biology of Ku and its potential oncogenic role in cancer. Biochim. Biophys. Acta 1765, 223-234